This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IntegraMed’s Attain Fertility Centers Expands Partner Network Via Acquisition Of Palmetto Fertility Center

IntegraMed ® America, Inc. (NASDAQ: INMD), the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that its Attain Fertility® Centers Division (AFC) acquired Palmetto Fertility Center (PFC) in Miami Lakes, FL. PFC to merge its operations with another Attain Fertility partner center, IVF Florida Reproductive Associates (IVFFL). No additional terms of the transaction were disclosed.

Dr. Michael D. Graubert, medical director for PFC, commented, "Given today's healthcare environment, we believe that merging with IVF Florida and working together with IntegraMed’s AFC division will provide us with a high level of support to grow our practice and further enhance the overall operations of the center. As part of IVF Florida, we look forward to opportunities to improve outcomes and quality care for our patients and their families in the greater Miami community."

With this acquisition, IVF Florida Reproductive Associates will represent over 40% market share in the South Florida region - defined as Broward, Palm Beach, Martin, St. Lucie and Miami-Dade counties – an area responsible for approximately 1,800 IVF cycles per year across more than 5.5 million residents. Palmetto Fertility Center includes a state-of-the-art fertility laboratory that will allow the combined operations to better service the growing Miami-Dade county market. PFC is currently staffed by two board-certified Reproductive Endocrinologists (REs) along with a lab director and additional office staff.

For over 25 years, IntegraMed’s Attain Fertility Centers division has helped partner practices grow faster and more profitably than they would have on their own. This partnership will help IVFFL to gain market share through AFC’s proven model for success, focused on:

  • Alignment through strategic planning and capital investments;
  • Operational Excellence by leveraging industry-leading standardized operations, administration, clinical tools, market research and shared services, and,
  • Growth through world-class marketing and a patient-centric approach that ensures partner practices continue to gain market share within their region.

Jay Higham, President and CEO of IntegraMed, commented, “We are pleased to see our fertility partner footprint continue to grow and build upon the organic growth we have been able to achieve. The Palmetto facility currently accounts for less than 10% of the overall market share, presenting a significant opportunity to gain market share by doing what we do best - increasing patient flow and operational efficiencies by managing the center’s operations and establishing improved patient outreach initiatives.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs